FBC
CCRN icon

Fairfield, Bush & Co’s Cross Country Healthcare CCRN Stock Holding History

Fairfield, Bush & Co’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed -$679 – 167
2023
Q4 		$679 Buy
+30
New +$650 ﹤0.01% 461
2023
Q3 		– Sell
-30
Closed -$842 – 164
2023
Q2 		$842 Buy
+30
New +$745 ﹤0.01% 472

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fairfield, Bush & Co's CCRN Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Cross Country Healthcare (CCRN) in Q1 2024, closing a stake of 30 shares — an estimated $679 sold.

Fairfield, Bush & Co first reported a position in CCRN in Q2 2023 and held it in 2 quarters. The position peaked at $842 in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Cross Country Healthcare position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 30 Cross Country Healthcare shares in Q1 2024, an estimated $679.
  • Fairfield, Bush & Co first reported a position in Cross Country Healthcare in Q2 2023 and held it in 2 quarters.
  • Fairfield, Bush & Co's Cross Country Healthcare position peaked at $842 in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.